- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.72 Å
- Oligo State
- monomer
- Ligands
- 1 x NA: SODIUM ION(Non-functional Binders)
- 1 x ZMA: 4-{2-[(7-amino-2-furan-2-yl[1,2,4]triazolo[1,5-a][1,3,5]triazin-5-yl)amino]ethyl}phenol(Non-covalent)
- 4 x CLR: CHOLESTEROL(Non-covalent)
CLR.3: 8 residues within 4Å:- Chain A: H.84, G.85, F.88, F.142, M.149
- Ligands: CLR.4, OLA.22, OLA.23
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:F.88, A:F.142
CLR.4: 8 residues within 4Å:- Chain A: F.71, A.81, A.82, G.85, F.88, I.89
- Ligands: CLR.3, OLC.30
6 PLIP interactions:6 interactions with chain A- Hydrophobic interactions: A:F.71, A:F.88, A:I.89, A:I.89
- Hydrogen bonds: A:A.82
- Water bridges: A:Q.172
CLR.5: 10 residues within 4Å:- Chain A: L.349, L.352, P.353, I.357, F.360, C.367, S.368, A.370, L.374
- Ligands: OLA.8
7 PLIP interactions:7 interactions with chain A- Hydrophobic interactions: A:L.349, A:L.352, A:P.353, A:I.357, A:F.360, A:L.374
- Hydrogen bonds: A:S.368
CLR.6: 9 residues within 4Å:- Chain A: F.191, L.196, I.356, C.359, F.360, F.363, C.364
- Ligands: OLA.19, OLB.28
7 PLIP interactions:7 interactions with chain A- Hydrophobic interactions: A:F.191, A:L.196, A:I.356, A:F.360, A:F.360, A:F.360, A:F.363
- 20 x OLA: OLEIC ACID(Non-covalent)(Non-functional Binders)
OLA.7: 8 residues within 4Å:- Chain A: P.70, I.73, T.74, T.77, F.79
- Ligands: OLA.13, OLA.24, OLC.30
Ligand excluded by PLIPOLA.8: 3 residues within 4Å:- Chain A: P.371, L.377
- Ligands: CLR.5
Ligand excluded by PLIPOLA.9: 2 residues within 4Å:- Chain A: G.345, L.346
Ligand excluded by PLIPOLA.10: 6 residues within 4Å:- Chain A: F.53, F.102, A.106, D.110, V.125, I.133
Ligand excluded by PLIPOLA.11: 5 residues within 4Å:- Chain A: G.14, L.372, Y.376, L.377, V.380
Ligand excluded by PLIPOLA.12: 4 residues within 4Å:- Chain A: I.136, A.143
- Ligands: OLA.16, OLA.21
Ligand excluded by PLIPOLA.13: 2 residues within 4Å:- Ligands: OLA.7, OLA.24
Ligand excluded by PLIPOLA.14: 6 residues within 4Å:- Chain A: L.28, L.31, G.32, L.35, W.38, F.391
Ligand excluded by PLIPOLA.15: 1 residues within 4Å:- Chain A: W.373
Ligand excluded by PLIPOLA.16: 6 residues within 4Å:- Chain A: T.128, R.129, G.132, I.136, V.139
- Ligands: OLA.12
Ligand excluded by PLIPOLA.17: 1 residues within 4Å:- Ligands: OLA.26
Ligand excluded by PLIPOLA.18: 4 residues within 4Å:- Chain A: V.34, C.37, W.41
- Ligands: OLB.29
Ligand excluded by PLIPOLA.19: 9 residues within 4Å:- Chain A: L.196, L.199, L.200, L.203, Y.206, A.341, A.344, A.348
- Ligands: CLR.6
Ligand excluded by PLIPOLA.20: 1 residues within 4Å:- Chain A: T.20
Ligand excluded by PLIPOLA.21: 5 residues within 4Å:- Chain A: A.143, M.149, L.150
- Ligands: OLA.12, OLA.22
Ligand excluded by PLIPOLA.22: 5 residues within 4Å:- Chain A: A.143, M.149
- Ligands: CLR.3, OLA.21, OLA.23
Ligand excluded by PLIPOLA.23: 6 residues within 4Å:- Chain A: I.134, A.135, F.142
- Ligands: CLR.3, OLA.22, OLC.31
Ligand excluded by PLIPOLA.24: 3 residues within 4Å:- Ligands: OLA.7, OLA.13, OLC.30
Ligand excluded by PLIPOLA.25: 4 residues within 4Å:- Chain A: S.15, I.19, L.23, T.77
Ligand excluded by PLIPOLA.26: 5 residues within 4Å:- Chain A: I.25, T.384, V.387, V.388
- Ligands: OLA.17
Ligand excluded by PLIP- 3 x OLB: (2S)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate(Non-covalent)
OLB.27: 4 residues within 4Å:- Chain A: Y.188, F.192, F.363
- Ligands: OLB.28
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:F.192, A:F.192
- Hydrogen bonds: A:Y.188
OLB.28: 6 residues within 4Å:- Chain A: F.192, L.196, F.363, P.365
- Ligands: CLR.6, OLB.27
5 PLIP interactions:5 interactions with chain A- Hydrophobic interactions: A:F.192, A:L.196, A:F.363, A:F.363
- Water bridges: A:D.366
OLB.29: 9 residues within 4Å:- Chain A: C.37, V.40, W.41, Y.52, V.55, A.59, I.62, L.63
- Ligands: OLA.18
6 PLIP interactions:6 interactions with chain A- Hydrophobic interactions: A:W.41, A:A.59, A:I.62, A:L.63
- Hydrogen bonds: A:Y.52, A:Y.52
- 2 x OLC: (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate(Non-covalent)
OLC.30: 10 residues within 4Å:- Chain A: V.66, L.67, P.70, F.71, T.74, F.79, C.80
- Ligands: CLR.4, OLA.7, OLA.24
10 PLIP interactions:10 interactions with chain A- Hydrophobic interactions: A:V.66, A:L.67, A:P.70, A:F.71, A:F.71, A:T.74, A:F.79
- Hydrogen bonds: A:C.80
- Water bridges: A:C.80, A:Q.172
OLC.31: 9 residues within 4Å:- Chain A: Y.52, V.55, L.63, G.127, A.131, I.134, W.138, F.142
- Ligands: OLA.23
5 PLIP interactions:5 interactions with chain A- Hydrophobic interactions: A:V.55, A:L.63, A:W.138, A:F.142
- Hydrogen bonds: A:G.127
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Segala, E. et al., Controlling the Dissociation of Ligands from the Adenosine A2A Receptor through Modulation of Salt Bridge Strength. J.Med.Chem. (2016)
- Release Date
- 2016-06-29
- Peptides
- Adenosine receptor A2a,Soluble cytochrome b562,Adenosine receptor A2a: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.72 Å
- Oligo State
- monomer
- Ligands
- 1 x NA: SODIUM ION(Non-functional Binders)
- 1 x ZMA: 4-{2-[(7-amino-2-furan-2-yl[1,2,4]triazolo[1,5-a][1,3,5]triazin-5-yl)amino]ethyl}phenol(Non-covalent)
- 4 x CLR: CHOLESTEROL(Non-covalent)
- 20 x OLA: OLEIC ACID(Non-covalent)(Non-functional Binders)
- 3 x OLB: (2S)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate(Non-covalent)
- 2 x OLC: (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Segala, E. et al., Controlling the Dissociation of Ligands from the Adenosine A2A Receptor through Modulation of Salt Bridge Strength. J.Med.Chem. (2016)
- Release Date
- 2016-06-29
- Peptides
- Adenosine receptor A2a,Soluble cytochrome b562,Adenosine receptor A2a: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A - Membrane
-
We predict this structure to be a membrane protein.